483
Wyeth BioPharma Division of Wyeth Pharmaceuticals LLCWyeth BioPharma Division of Wyeth Pharmaceuticals LLC – FDA 483, Sep 19, 2023
Record Details
Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC in Andover, MA, a biological drug substance manufacturer, was cited with three observations during an FDA inspection. The observations highlight significant concerns regarding process control, including the exclusion of continuous process verification data, inadequate temperature control for drug substance shipping, and an unjustified "non-CQA" designation for a critical attribute, indicating potential risks to product safety and efficacy.
- Inspection date
- September 19, 2023
- Product type
- biologics
View Company Profile
ID · 7326d811-b200-4ac7-ae4e-783a9762d90c
Other documents for Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.